Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Johnson & Johnson (NY:JNJ)

218.49 +0.48 (+0.22%)

Official Closing Price Updated: 7:00 PM EST, Jan 22, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	13,160,025
Open	218.77
Bid (Size)	218.01 (100)
Ask (Size)	220.00 (300)
Prev. Close	218.01
Today's Range	218.10 - 222.17
52wk Range	141.50 - 222.17
Shares Outstanding	2,628,679,824
Dividend Yield	2.38%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The Biotech Renaissance: Scientific Breakthroughs and M&A Frenzy Spark a New Bull Market

Today 14:39 EST

The U.S. biotech sector has officially entered a new golden age. As of January 22, 2026, the industry is witnessing a "renaissance" that has effectively erased the memories of the grueling three-year...

Via MarketMinute

I Correctly Predicted That These 15 Dow Jones Stocks Would Boost Their Payouts in 2025. Here's Why It Can Happen Again in 2026. ↗

Today 14:35 EST

The Dow is chock-full of high-quality companies that pay growing dividends.

Via The Motley Fool

Performance

YTD	+5.4%	+5.4%
1 Month	+6.2%	+6.2%
3 Month	+13.5%	+13.5%
6 Month	+28.9%	+28.9%
1 Year	+50.4%	+50.4%

More News

Johnson & Johnson (NYSE:JNJ) Beats Q4 Estimates but Stock Dips on 2026 Guidance ↗

January 21, 2026

Via Chartmill

Resilience in the Face of the Patent Cliff: Johnson & Johnson Forecasts Landmark 2026 Growth

Today 11:52 EST

Via MarketMinute

Johnson & Johnson Analyst Raises Price Target On Several Tailwinds In 2026 ↗

Today 11:03 EST

Via Benzinga

The Davos Pivot: Trump’s Tariff U-Turn Sends Markets Into a Greenland Glow ↗

Today 3:00 EST

Via Chartmill

This 2.4%-Yielding Dividend King Remains As Healthy As Ever ↗

Today 2:05 EST

Via The Motley Fool

S&P 500 Jumps Over 1% As Trump Withdraws EU Tariff Threat: Investor Sentiment Improves, Fear & Greed Index Remains In 'Neutral' Zone ↗

Today 1:41 EST

Via Benzinga

Is This Dividend King Stock a Buy After a Major Development? ↗

January 21, 2026

Via The Motley Fool

J&J Forecasts $100 Billion Milestone for 2026 as Trump Drug Pricing Deals Reshape the Pharma Landscape

January 21, 2026

Via MarketMinute

Johnson & Johnson (JNJ) Earnings Call Transcript ↗

January 21, 2026

Via The Motley Fool

Discover the top S&P500 movers in Wednesday's pre-market session. ↗

January 21, 2026

Via Chartmill

Johnson & Johnson Posts Q4 2025 Revenue Beat, EPS Comes Up Short ↗

January 21, 2026

Via Talk Markets

Johnson & Johnson reports Q4 and Full-Year 2025 results

January 21, 2026

From Johnson & Johnson

Via Business Wire

Nasdaq, S&P 500 Futures Rebound, All Eyes On Trump’s Davos Speech: Why TSLA, NVDA, NFLX, AVR Are On Traders' Radar Today ↗

January 21, 2026

Via Stocktwits

Dow, Nasdaq, S&P 500 Futures Tick Higher After Wall Street’s Worst Day In 3 Months: Why NFLX, AAPL, CRVS, GME, UAL Are In Focus Today ↗

January 20, 2026

Via Stocktwits

The Titan’s Balance: Johnson & Johnson Reaches Record Highs Amidst Legal Hurdles and Med-Tech Transformation

January 20, 2026

Via MarketMinute

The New Titan of Wellness: Kimberly-Clark’s $48.7 Billion Kenvue Acquisition Reshapes Consumer Staples

January 20, 2026

Via MarketMinute

The M&A Renaissance: 2026 Set to Eclipse a Record-Breaking 2025 as AI and Regulatory Clarity Drive Deal Supercycle

January 20, 2026

Via MarketMinute

The High-Stakes Balancing Act: Johnson & Johnson Braces for Q4 Earnings Amid Patent Cliffs and MedTech Expansion

January 20, 2026

Via MarketMinute

Johnson & Johnson Near 52-Week High As CAPLYTA Data Boosts Sentiment ↗

January 20, 2026

Via Talk Markets

How To Earn $500 A Month From Johnson & Johnson Stock Ahead Of Q4 Earnings ↗

January 20, 2026

Via Benzinga

Option Volatility And Earnings Report For January 20 - 23

January 20, 2026

Via Barchart.com

Johnson & Johnson's $10 Billion Test: 2026 Outlook Could Make Or Break JNJ Heading Into Q4 ↗

January 20, 2026

Via Benzinga

The New Era of Johnson & Johnson: A 2026 Deep-Dive Research Feature

January 19, 2026

Via Finterra

Frequently Asked Questions

Is Johnson & Johnson publicly traded?

Yes, Johnson & Johnson is publicly traded.

What exchange does Johnson & Johnson trade on?

Johnson & Johnson trades on the New York Stock Exchange

What is the ticker symbol for Johnson & Johnson?

The ticker symbol for Johnson & Johnson is JNJ on the New York Stock Exchange

What is the current price of Johnson & Johnson?

The current price of Johnson & Johnson is 218.49

When was Johnson & Johnson last traded?

The last trade of Johnson & Johnson was at 01/22/26 07:00 PM ET

What is the market capitalization of Johnson & Johnson?

The market capitalization of Johnson & Johnson is 574.34B

How many shares of Johnson & Johnson are outstanding?

Johnson & Johnson has 574B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.